Literature DB >> 21802535

Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding.

Anne von Zychlinski1, Torsten Kleffmann, Michael J A Williams, Sally P McCormick.   

Abstract

Lipoprotein(a) [Lp(a)] is a major independent risk factor for cardiovascular disease. Twenty percent of the general population exhibit levels above the risk threshold highlighting the importance for clinical and basic research. Comprehensive proteomics of human Lp(a) will provide significant insights into Lp(a) physiology and pathogenicity. Using liquid chromatography-coupled mass spectrometry, we established a high confidence Lp(a) proteome of 35 proteins from highly purified particles. Protein interaction network analysis and functional clustering revealed proteins assigned to the two major biological processes of lipid metabolism and response to wounding. The latter includes the processes of coagulation, complement activation and inflammatory response. Furthermore, absolute protein quantification of apoB-100, apo(a), apoA1, complement C3 and PON1 gave insights into the compositional stoichiometry of associated proteins per particle. Our proteomics study has identified Lp(a)-associated proteins that support a suggested role of Lp(a) in response to wounding which points to mechanisms of Lp(a) pathogenicity at sites of vascular injury and atherosclerotic lesions. This study has identified a high confidence Lp(a) proteome and provides an important basis for further comparative and quantitative analyses of Lp(a) isolated from greater numbers of plasma samples to investigate the significance of associated proteins and their dynamics for Lp(a) pathogenicity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802535     DOI: 10.1016/j.jprot.2011.07.008

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  15 in total

1.  Increased expression of ApoA1 after neuronal injury may be beneficial for healing.

Authors:  Mohor B Sengupta; Suparna Saha; Pradeep K Mohanty; Kiran K Mukhopadhyay; Debashis Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2016-10-13       Impact factor: 3.396

Review 2.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

3.  A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research.

Authors:  Paul A Mueller; Elisabeth Yerkes; Paige Bergstrom; Sara Rosario; Joshua Hay; Nathalie Pamir
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

4.  Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein.

Authors:  Alejandro Gugliucci; Russell Caccavello; Kazuhiko Kotani; Satoshi Kimura
Journal:  Redox Rep       Date:  2014-02-14       Impact factor: 4.412

5.  A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization.

Authors:  Raphaëlle Bourgeois; Arnaud Girard; Nicolas Perrot; Jakie Guertin; Patricia L Mitchell; Christian Couture; Clarisse Gotti; Sylvie Bourassa; Paolo Poggio; Elvira Mass; Romain Capoulade; Corey A Scipione; Audrey-Anne Després; Patrick Couture; Arnaud Droit; Philippe Pibarot; Michael B Boffa; Sébastien Thériault; Marlys L Koschinsky; Patrick Mathieu; Benoit J Arsenault
Journal:  CJC Open       Date:  2020-12-03

6.  Lipoprotein(a): Cellular Effects and Molecular Mechanisms.

Authors:  Kirsten Riches; Karen E Porter
Journal:  Cholesterol       Date:  2012-09-06

7.  Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Authors:  Monika Sharma; Anne Von Zychlinski-Kleffmann; Carolyn M Porteous; Gregory T Jones; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2015-04-06       Impact factor: 5.922

8.  Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker.

Authors:  Antonio J Lepedda; Gabriele Nieddu; Elisabetta Zinellu; Pierina De Muro; Franco Piredda; Anna Guarino; Rita Spirito; Franco Carta; Francesco Turrini; Marilena Formato
Journal:  Oxid Med Cell Longev       Date:  2013-12-24       Impact factor: 6.543

9.  Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.

Authors:  Kirsten A Berk; Reyhana Yahya; Adrie J M Verhoeven; Jeanette Touw; Frank P Leijten; Elisabeth F van Rossum; Vincent L Wester; Mirjam A Lips; Hanno Pijl; Reinier Timman; Gertraud Erhart; Florian Kronenberg; Jeanine E Roeters van Lennep; Eric J G Sijbrands; Monique T Mulder
Journal:  Diabetologia       Date:  2017-04-06       Impact factor: 10.122

10.  Establishment of Relational Model of Congenital Heart Disease Markers and GO Functional Analysis of the Association between Its Serum Markers and Susceptibility Genes.

Authors:  Min Liu; Luosha Zhao; Jiaying Yuan
Journal:  Comput Math Methods Med       Date:  2016-03-16       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.